IGHE and allergic asthma: By the use of the objective laboratory method CD‐sens, which effectively measures the direct effect of omalizumab, that is, the IgE‐mediated part of the allergic asthma, in combination with clinical parameters, it might be possible to more effectively monitor and treat IgE‐mediated allergic asthma.